Back to search
FDAFDA · Food and drugs·Recall number D-0889-2022

Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3

Published June 1, 2022 · Recall initiated: May 6, 2022

Summary

FDA records drug Class II recall D-0889-2022, published June 1, 2022 and initiated May 6, 2022. Recalling firm: Noven Pharmaceuticals Inc; Status: Ongoing; Reported quantity: 274, 110 patches; Lot: Lot: 90764 Exp. 08/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: customer complaints exceeded respective action limits.

What to do

Voluntary: Firm initiated · Letter

Get an email if DAYTRANA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DAYTRANA
Manufacturer
Noven Pharmaceuticals Inc
Distributor
Nationwide to the U.S. Market
Lot
Lot: 90764 Exp. 08/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3 recalled?

Yes. FDA published recall D-0889-2022 on June 1, 2022. Reported hazard: Defective Delivery System: customer complaints exceeded respective action limits.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DAYTRANA.